Rapid detection of cefiderocol susceptibility/resistance in Acinetobacter baumannii

The prospective role of cefiderocol in the management of carbapenem-resistant Acinetobacter baumannii infections: review of the evidence

(2023) Marin Kollef et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Mechanisms of Reduced Susceptibility to Cefiderocol Among Isolates from the CREDIBLE-CR and APEKS-NP Clinical Trials

(2022) Patrice Nordmann et al.   Microbial Drug Resistance

Evolution and transmission of cefiderocol-resistant Acinetobacter baumannii during an outbreak in the burn intensive care unit

(2022) Steven M Smoke et al.   CLINICAL INFECTIOUS DISEASES

Rapid cefiderocol NP test for detection of cefiderocol susceptibility/resistance in Enterobacterales

(2022) Patrice Nordmann et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Contribution of PER-Type and NDM-Type β-Lactamases to Cefiderocol Resistance in Acinetobacter baumannii

(2021) Laurent Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cefiderocol Antimicrobial Susceptibility Testing against Multidrug-Resistant Gram-negative Bacilli: A Comparison of Disk Diffusion to Broth Microdilution

(2020) C. Paul Morris et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Targeting Multidrug-Resistant Acinetobacter spp.: Sulbactam and the Diazabicyclooctenone β-Lactamase Inhibitor ETX2514 as a Novel Therapeutic Agent

(2019) Melissa D. Barnes et al.   mBio

Global spread of carbapenem-resistant Acinetobacter baumannii

(2009) P. G. Higgins et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY